Personal information

Verified email domains

stem cell, cell metabolism, molecular biology
United Kingdom

Biography

Wenjuan Ma currently works as the research associate at Wellcome - MRC Cambridge Stem Cell Institute of University of Cambridge. She got her PhD degree of medical sciences in 2021 at Kumamoto University in Japan and then she moved to Prof Toshio Suda's lab and worked on stem cell metabolism.

Activities

Employment (3)

University of Cambridge: Cambridge, Cambridgeshire, GB

2023-03-27 to present | Research Associate (Wellcome-MRC Cambridge Stem Cell Institute)
Employment
Source: Self-asserted source
Wenjuan Ma

Kumamoto University: Kumamoto, Kumamoto, JP

2021-04-01 to 2023-03-22 | Research Scientist (International Research Center for Medical Sciences (IRCMS))
Employment
Source: Self-asserted source
Wenjuan Ma

Kumamoto University: Kumamoto, Kumamoto, JP

2019-04-01 to 2021-03-31 | JSPS-DC2 Research Fellow (International Research Center for Medical Sciences (IRCMS))
Employment
Source: Self-asserted source
Wenjuan Ma

Education and qualifications (2)

Kumamoto University: Kumamoto, JP

2017-04-01 to 2021-03-31 | PhD (IRCMS)
Education
Source: Self-asserted source
Wenjuan Ma

Southern Medical University: Guangzhou, CN

2011-09-01 to 2016-07-01 | MD (The second clinical medicine college)
Education
Source: Self-asserted source
Wenjuan Ma

Works (7)

Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle

Blood
2024-08-15 | Journal article
Contributors: Carys S. Johnson; Matthew Williams; Kendig Sham; Serena Belluschi; Wenjuan Ma; Xiaonan Wang; Winnie W. Y. Lau; Kerstin B. Kaufmann; Gabriela Krivdova; Emily F. Calderbank et al.
Source: check_circle
Crossref

MITOL deficiency triggers hematopoietic stem cell apoptosis via ER stress response

The EMBO Journal
2024-01-18 | Journal article
Contributors: Wenjuan Ma; Shah Adil Ishtiyaq Ahmad; Michihiro Hashimoto; Ahad Khalilnezhad; Miho Kataoka; Yuichiro Arima; Yosuke Tanaka; Shigeru Yanagi; Terumasa Umemoto; Toshio Suda
Source: check_circle
Crossref

Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.

Cancer science
2022-05-04 | Journal article
Contributors: Funasaki S; Sally Mehanna; Ma W; Nishizawa H; Yasuhiko Kamikubo; Sugiyama H; Ikeda S; Motoshima T; Hisashi Hasumi; Linehan WM et al.
Source: Self-asserted source
Wenjuan Ma

Establishment of bone marrow-derived M-CSF receptor-dependent self-renewing macrophages.

Cell death discovery
2020-07-23 | Journal article
Contributors: Hesham Nasser; Partho Protim Adhikary; Amira Abdel-daim; Noyori O; Jutatip Panaampon; Kariya R; Seiji Okada; Ma W; Baba M; Takizawa H et al.
Source: Self-asserted source
Wenjuan Ma

TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.

Molecular cancer research : MCR
2019-05-01 | Journal article
Contributors: Masaya Baba; Mitsuko Furuya; Motoshima T; Martin Lang; Funasaki S; Ma W; Hong-Wei Sun; Hasumi H; Huang Y; Ikuma Kato et al.
Source: Self-asserted source
Wenjuan Ma

Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation

Journal of Bone and Mineral Research
2018-10 | Journal article
Part of ISSN: 0884-0431
Contributors: Masaya Baba; Mitsuhiro Endoh; Wenjuan Ma; Hirofumi Toyama; Akiyoshi Hirayama; Keizo Nishikawa; Keiyo Takubo; Hiroyuki Hano; Hisashi Hasumi; Terumasa Umemoto et al.
Source: Self-asserted source
Wenjuan Ma

Catheter Ablation Resolves Ventricular Arrhythmias in a Patient with Sarcoidosis.

International journal of cardiology
2015-08-10 | Journal article
Contributors: Ma W; Song X; Wang X; Zhong W; Deng Y; Yang P
Source: Self-asserted source
Wenjuan Ma

Peer review (1 review for 1 publication/grant)

Review activity for Experimental hematology. (1)